Award
NIH Reporter #5R01CA282759-04
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
Recipient
CHILDREN'S HOSPITAL OF LOS ANGELES
Award Amount
$561,836.00
Ceiling
$561,836.00
Awarded
August 11, 2026
Identifier
5R01CA282759-04
Award for validating liquid biopsy methods to improve diagnosis and prognosis of retinoblastoma in children.
Description
This project involves the validation of liquid biopsy techniques for retinoblastoma, including molecular characterization and biomarker validation, with a focus on improving diagnosis and prognosis through multi-omics and longitudinal studies.